3T MRI-Compatible Small Body Array Gets FDA Nod
Featuring a lightweight body contouring design, the Small Body Array reportedly facilitates optimal signal-to-noise ratio (SNR) and between 10 and 40 percent faster throughput.
The Food and Drug Administration (FDA) has granted 510(k) clearance for a 3T magnetic resonance imaging (MRI)-compatible Small Body Array, which emphasizes a body contouring design and coils that are 80 percent lighter than conventional coils.
The body-hugging design of the Small Body Array adapts to a wide range of patient anatomies and sizes, according to InkSpace Imaging, the developer of the Small Body Array. The company emphasized that the Small Body Array provides optimal signal-to-noise ration (SNR), which improves detection of subtle abnormalities that may be missed by conventional coils.
In addition to increased patient comfort, InkSpace Imaging said the Small Body Array offers high coil element density, which helps streamline MRI acquisition. The company noted that the coils with the Small Body Array allow up to 40 percent faster throughput.
“The FDA clearance of InkSpace Imaging's Small Body Array marks a pivotal moment in MRI technology advancement. Our suite of MR coils is a game-changer, offering total freedom in coil positioning and handling,” noted Peter Fischer, the CEO of InkSpace Imaging. “What's truly impressive is how our thin flexible coil contours to each patient's body, offering comfort while enhancing image quality. It's a win-win for patients and health-care providers alike."
InkSpace Imaging said the Small Body Array is compatible with the Magnetom Skyra (Siemens Healthineers) and Magnetom Vida (Siemens Healthineers) series 3T MRI scanners.
Recent Videos
Related Content
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025Article
New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy
May 2nd 2025Article
Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.
